Do you still consider the use of pegloticase in someone with substantial tophaceous burden despite optimal uric acid levels?
For example, patient with sUA <4 already on maximum dose allopurinol or Uloric, but significant tophi that have only marginally reduced in size.
1 Answer
Mednet MemberInvited Expert
Rheumatology · National institues of Health
Answered on · Updated on
If a patient has a significant burden of tophaceous deposits causing functional impairment despite serum uric acid control achieved through oral uric acid lowering therapy (ULT), I strongly recommend considering a course of enzymatic therapy with pegloticase. Terms such as “treatment failure gout” o...
Join for free or sign in to see the full answer